DSP107 combines inhibition of CD47/SIRPα axis with activation of 4-1BB to trigger anticancer immunity https://t.co/98mQ57X5w2 https://t.co/lhJWQloWRg
74 followers
1,722 followers
𝐃𝐒𝐏𝟏𝟎𝟕 𝐜𝐨𝐦𝐛𝐢𝐧𝐞𝐬 𝐢𝐧𝐡𝐢𝐛𝐢𝐭𝐢𝐨𝐧 𝐨𝐟 𝐂𝐃𝟒𝟕/𝐒𝐈𝐑𝐏α 𝐚𝐱𝐢𝐬 𝐰𝐢𝐭𝐡 𝐚𝐜𝐭𝐢𝐯𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝟒-𝟏𝐁𝐁 𝐭𝐨 𝐭𝐫𝐢𝐠𝐠𝐞𝐫 𝐚𝐧𝐭𝐢𝐜𝐚𝐧𝐜𝐞𝐫 #𝐢𝐦𝐦𝐮𝐧𝐢𝐭𝐲
524 followers
RT @JournalofExper1: New!💥 𝐃𝐒𝐏𝟏𝟎𝟕 𝐜𝐨𝐦𝐛𝐢𝐧𝐞𝐬 𝐢𝐧𝐡𝐢𝐛𝐢𝐭𝐢𝐨𝐧 𝐨𝐟 𝐂𝐃𝟒𝟕/𝐒𝐈𝐑𝐏α 𝐚𝐱𝐢𝐬 𝐰𝐢𝐭𝐡 𝐚𝐜𝐭𝐢𝐯𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝟒-𝟏𝐁𝐁 𝐭𝐨 𝐭𝐫𝐢𝐠𝐠𝐞𝐫 𝐚𝐧𝐭𝐢𝐜𝐚𝐧𝐜𝐞𝐫 #𝐢𝐦𝐦𝐮𝐧𝐢𝐭𝐲 For fre…
524 followers
New!💥 𝐃𝐒𝐏𝟏𝟎𝟕 𝐜𝐨𝐦𝐛𝐢𝐧𝐞𝐬 𝐢𝐧𝐡𝐢𝐛𝐢𝐭𝐢𝐨𝐧 𝐨𝐟 𝐂𝐃𝟒𝟕/𝐒𝐈𝐑𝐏α 𝐚𝐱𝐢𝐬 𝐰𝐢𝐭𝐡 𝐚𝐜𝐭𝐢𝐯𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝟒-𝟏𝐁𝐁 𝐭𝐨 𝐭𝐫𝐢𝐠𝐠𝐞𝐫 𝐚𝐧𝐭𝐢𝐜𝐚𝐧𝐜𝐞𝐫 #𝐢𝐦𝐦𝐮𝐧𝐢𝐭𝐲 For free 🖥️ https://t.co/bS5RXK8C3x #BcellLymphoma @IREISGufficiale https://t.co/XFS6JXgn97